中文 | English
Return
Total: 143 , 1/15
Show Home Prev Next End page: GO
Author:(Mi-Fang LI)

1.Clinical Observation of Modified Zhigancao Tang in Treating Patients with Liver and Kidney Deficiency of Parkinson's Disease and Its Effect on Neuronal Signal-related Proteins

Yifo WEI ; Furong LYU ; Jia YAO ; Guonian LI ; Xianyi LUO ; Meng LUO ; Zhengzheng WEN ; Qiuqi LI ; Yihan LIU ; Linlin YANG ; Rui ZUO ; Wenxin DANG ; Fang MI ; Xiaoyan WANG ; Zhigang CHEN ; Fan LIU

Chinese Journal of Experimental Traditional Medical Formulae 2025;31(4):166-173

2.Acupuncture at Weizhong (BL40) attenuates acetic acid-induced overactive bladder in rats by regulating brain neural activity through the modulation of mast cells and tibial nerves.

Xin LIU ; Chao-Yue ZHANG ; Xiu-Yu DU ; Shan-Shan LI ; Yu-Qing WANG ; Yi ZHENG ; Han-Zhi DENG ; Xiao-Qin FANG ; Jia-Ying LI ; Zu-Qing WANG ; Shi-Fen XU ; Yi-Qun MI

Journal of Integrative Medicine 2025;23(1):46-55

3.Clinical trial of Morinda officinalis oligosaccharides in the continuation treatment of adults with mild and moderate depression

Shu-Zhe ZHOU ; Zu-Cheng HAN ; Xiu-Zhen WANG ; Yan-Qing CHEN ; Ya-Ling HU ; Xue-Qin YU ; Bin-Hong WANG ; Guo-Zhen FAN ; Hong SANG ; Ying HAI ; Zhi-Jie JIA ; Zhan-Min WANG ; Yan WEI ; Jian-Guo ZHU ; Xue-Qin SONG ; Zhi-Dong LIU ; Li KUANG ; Hong-Ming WANG ; Feng TIAN ; Yu-Xin LI ; Ling ZHANG ; Hai LIN ; Bin WU ; Chao-Ying WANG ; Chang LIU ; Jia-Fan SUN ; Shao-Xiao YAN ; Jun LIU ; Shou-Fu XIE ; Mao-Sheng FANG ; Wei-Feng MI ; Hong-Yan ZHANG

The Chinese Journal of Clinical Pharmacology 2024;40(6):815-819

4.Expert consensus on the prevention and control of intracranial hypertension in adult critical illness

The Critical Care Professional Committee of the Chinese Nursing Association ; Fang LIU ; Yujiao WANG ; Xiaobai CAO ; Lan GAO ; Songbai XU ; Yuanyuan MI ; Hong SUN ; Fengru MIAO ; Yan LI ; Hongyan LI

Chinese Journal of Nursing 2024;59(21):2606-2610

5.Difference analysis of ADE signal for irinotecan in adults and children

Fang LI ; Xiaohuan DU ; Xiang SHANG ; Wenjuan WANG ; Mi ZHOU ; Zengyan ZHU

China Pharmacy 2024;35(11):1369-1373

6.Difference analysis of ADE signal for irinotecan in adults and children

Fang LI ; Xiaohuan DU ; Xiang SHANG ; Wenjuan WANG ; Mi ZHOU ; Zengyan ZHU

China Pharmacy 2024;35(11):1369-1373

7.The trend and challenge of DNA methylation clinical application in cervical cancer

Yuli LIU ; Xiaobing XIE ; Fei CHEN ; Weizhen LOU ; Ma MI ; Fang LI

Chinese Journal of Laboratory Medicine 2023;46(4):341-346

8.Reliability and validity of the Chinese version of adverse childhood experiences international questionnaire in parents of preschool children.

Xiao Yi MI ; Shan Shan HOU ; Zi Yuan FU ; Mo ZHOU ; Xin Xuan LI ; Zhao Xue MENG ; Hua fang JIANG ; Hong ZHOU

Journal of Peking University(Health Sciences) 2023;55(3):408-414

9.Clinical trial of bevacizumab in the treatment of platinum-resistant ovarian cancer,tubal cancer and peritoneal carcinoma patients

Shu-Fang MI ; Li-Mei ZHANG ; Mo LI ; Cai-Juan LIANG

The Chinese Journal of Clinical Pharmacology 2023;39(23):3379-3383

10.Hydroxysafflor yellow A inhibits proliferation, migration, and chemoresistance of colorectal cancer cells through Akt/mTOR-autophagy pathway.

Li WANG ; Fang LI ; Ni-Ni GU ; Hui SHEN ; Cai-Li HAN ; Kai-Yang LI ; Rui-Yang YAN ; Jue WANG ; Zhi-Kuan MI

China Journal of Chinese Materia Medica 2023;48(2):517-524

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 143 , 1/15 Show Home Prev Next End page: GO